Skip to content

Wednesday, 4 November 2026

United Therapeutics (UTHR) Q3 2026 Earnings Call Transcript

From The Motley Fool 4 Nov 2026, 18:28 UTC 1 min read

Tyvaso DPI growth lifted revenue while R&D spending weighed on profit.

Full story

Continue reading this story on The Motley Fool, the publisher that reported it.

Read the full story at The Motley Fool ↗

AI tools

Written by AI from the article text. It can make mistakes; check the original story.

Topics in this story

More from Business

See all

Business

Hackers stole DreamHost customer files and inboxes during months-long attack

34 min ago

Business

Clorox vs. PepsiCo: Which Dividend Stock Could Make You Richer Over the Next 10 Years?

41 min ago

Business

Delta vs. United: Could Falling Oil Prices Set the Stage for an Airline Stock Comeback in 2027?

41 min ago

Business

Prediction: Micron Stock Will Triple in 2027

41 min ago

Business

Here’s Why Dividend Kings Coca-Cola, Procter & Gamble, and Colgate-Palmolive Are Hitting 52-Week Highs Following Midterm Election Results

56 min ago

Business

Shopify Could Be the Best Growth Stock to Buy With $1,000 in November

1 hour ago